Biomarkers
A Biomarker can be described as an indicator of biological function or activity or a defined characteristic that is measured as an indicator of normal biological responses, pathogenic processes or a biological response to an exposure. Biomarkers might be therefore be soluble proteins, cell populations, molecular biomarkers (DNA or RNA) or a biological process (e.g., blood pressure).
At Agilex, we use a context-of-use (COU) framework for Biomarker assays. The COU is a concise description of the biomarker’s specified use in the study. Each qualification or validation effort for a biomarker should identify a single COU, to understand the purpose of the biomarker to guide assay selection at the outset and to provide an understanding of the expected data (expected fold change of dosed individuals compared with pre-dose/basal or expected pharmacodynamic changes elicited by the therapeutic).

Scientific Expertise
The Agilex Scientific team have considerable experience in setting up off the shelf or custom biomarker assays to support a study. We use LC-MS/MS, LBA (single or multiplex assay), Gyros to measure soluble biomarkers in a range of matrices (serum, plasma, urine, CSF, feces, saliva, tissues) in healthy and diseased matrix. We use Flow cytometry and ELISpot to enumerate biomarkers from single cells and PCR to detect molecular biomarkers (DNA, RNA).